190 77 Pill - peach capsule/oblong, 11mm
Pill with imprint 190 77 is Peach, Capsule/Oblong and has been identified as Capecitabine 150 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Capecitabine is used in the treatment of Colorectal Cancer; Breast Cancer, Metastatic; Breast Cancer; Pancreatic Cancer; Stomach Cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 190 77
Capecitabine
- Imprint
- 190 77
- Strength
- 150 mg
- Color
- Peach
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
- Inactive Ingredients
-
lactose anhydrous,
croscarmellose sodium,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7473 | Teva Pharmaceuticals USA, Inc. |
| 42291-0190 (Discontinued) | AvKare, Inc. |
More about capecitabine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (56)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
